Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)
Poor patient survival for non-uterine serous cancer at undesignated primary site Further studies needed to explore reasons for non-surgical treatment of serous cancer. International standardized criteria for primary site assignment of serous cancer needed Serous cancer of undesignated site should be included when reporting survival rates.